{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:21:45Z","timestamp":1772166105688,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Postdoctoral Research Fund, West China Hospital, Sichuan University","award":["2023HXBH040"],"award-info":[{"award-number":["2023HXBH040"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82120108015"],"award-info":[{"award-number":["82120108015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371925"],"award-info":[{"award-number":["82371925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes mellitus (DM) is the most common metabolic disease worldwide and a major risk factor for adverse cardiovascular events, while the additive effects of DM on left ventricular (LV) deformation in the restrictive cardiomyopathy (RCM) cohort remain unclear. Accordingly, we aimed to investigate the additive effects of DM on LV deformation in patients with RCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>One hundred thirty-six RCM patients without DM [RCM(DM\u2212)], 46 with DM [RCM (DM+)], and 66 age- and sex-matched control subjects who underwent cardiac magnetic resonance (CMR) scanning were included. LV function, late gadolinium enhancement (LGE) type, and LV global peak strains (including radial, circumferential, and longitudinal directions) were measured. The determinant of reduced LV global myocardial strain for all RCM patients was assessed using multivariable linear regression analyses. The receiver operating characteristic curve (ROC) was performed to illustrate the relationship between DM and decreased LV deformation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the control group, RCM (DM\u2212) and RCM(DM+) patients presented increased LV end-diastolic index and end-systolic volume index and decreased LV ejection fraction. LV GPS in all three directions and longitudinal PDSR progressively declined from the control group to the RCM(DM\u2212) group to the RCM(DM+) group (all p\u2009&lt;\u20090.05). DM was an independent determinant of impaired LV GPS in the radial, circumferential, and longitudinal directions and longitudinal PDSR (\u03b2\u2009=\u2009\u2009\u2212\u20090.217, 0.176, 0.253, and \u2212\u20090.263, all p\u2009&lt;\u20090.05) in RCM patients. The multiparameter combination, including DM, showed an AUC of 0.81(95% CI 0.75\u20130.87) to predict decreased LV GLPS and an AUC of 0.69 (95% CI 0.62\u20130.76) to predict decreased LV longitudinal PDSR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DM may have an additive deleterious effect on LV dysfunction in patients with RCM, especially diastolic dysfunction in RCM patients, indicating the importance of early identification and initiation of treatment of DM in patients with RCM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-02033-w","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:02:43Z","timestamp":1700474563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of diabetes mellitus on left ventricular function and deformation in patients with restrictive cardiomyopathies: a 3.0T CMR feature tracking study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yue","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"2033_CR1","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1093\/eurheartj\/ehac430","volume":"43","author":"F Crea","year":"2022","unstructured":"Crea F. The burden of cardiovascular risk factors: a global perspective. Eur Heart J. 2022;43:2817\u201320.","journal-title":"Eur Heart J"},{"key":"2033_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"C-X Ma","year":"2022","unstructured":"Ma C-X, Ma X-N, Guan C-H, Li Y-D, Mauricio D, Fu S-B. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21:74.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"2033_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"G Frati","year":"2017","unstructured":"Frati G, Schirone L, Chimenti I, Yee D, Biondi-Zoccai G, Volpe M, et al. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc Res. 2017;113:378\u201388.","journal-title":"Cardiovasc Res"},{"key":"2033_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-023-01850-3","volume":"22","author":"M M\u00e4enp\u00e4\u00e4","year":"2023","unstructured":"M\u00e4enp\u00e4\u00e4 M, Kujala I, Harjulahti E, Stenstr\u00f6m I, Nammas W, Knuuti J, et al. The impact of diabetes on the relationship of coronary artery disease and outcome: a study using multimodality imaging. Cardiovasc Diabetol. 2023;22:129.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270\u20136.","journal-title":"Eur Heart J"},{"key":"2033_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","volume":"121","author":"E Muchtar","year":"2017","unstructured":"Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathy. Circ Res. 2017;121:819\u201337.","journal-title":"Circ Res"},{"key":"2033_CR8","first-page":"108","volume":"23","author":"M Chintanaphol","year":"2022","unstructured":"Chintanaphol M, Orgil B-O, Alberson NR, Towbin JA, Purevjav E. Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling. RCM. 2022;23:108.","journal-title":"RCM"},{"key":"2033_CR9","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023;44:3503\u2013626.","journal-title":"Eur Heart J"},{"key":"2033_CR10","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s11547-020-01287-8","volume":"125","author":"N Galea","year":"2020","unstructured":"Galea N, Polizzi G, Gatti M, Cundari G, Figuera M, Faletti R. Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. Radiol med. 2020;125:1072\u201386.","journal-title":"Radiol med"},{"key":"2033_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/cvr\/cvy038","volume":"114","author":"O Sorop","year":"2018","unstructured":"Sorop O, Heinonen I, van Kranenburg M, van de Wouw J, de Beer VJ, Nguyen ITN, et al. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res. 2018;114:954\u201364.","journal-title":"Cardiovasc Res"},{"key":"2033_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0735-1097(03)00625-9","volume":"42","author":"M Diamant","year":"2003","unstructured":"Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JWA, Bax JJ, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 2003;42:328\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"2033_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12933-018-0782-0","volume":"17","author":"X Liu","year":"2018","unstructured":"Liu X, Yang Z, Gao Y, Xie L, Jiang L, Hu B, et al. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study. Cardiovasc Diabetol. 2018;17:139.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","volume":"9","author":"S Raina","year":"2016","unstructured":"Raina S, Lensing SY, Nairooz RS, Pothineni NVK, Hakeem A, Bhatti S, et al. Prognostic value of late\u00a0gadolinium\u00a0enhancement CMR in\u00a0systemic amyloidosis. JACC Cardiovasc Imaging. 2016;9:1267\u201377.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2033_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jacc.2019.12.024","volume":"75","author":"F Namazi","year":"2020","unstructured":"Namazi F, van der Bijl P, Hirasawa K, Kamperidis V, van Wijngaarden SE, Mertens B, et al. Prognostic value of left ventricular global longitudinal strain in patients with secondary mitral regurgitation. J Am Coll Cardiol. 2020;75:750\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"2033_CR16","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1007\/s00330-021-08346-2","volume":"32","author":"S Yu","year":"2022","unstructured":"Yu S, Chen X, Yang K, Wang J, Zhao K, Dong W, et al. Correlation between left ventricular fractal dimension and impaired strain assessed by cardiac MRI feature tracking in patients with left ventricular noncompaction and normal left ventricular ejection fraction. Eur Radiol. 2022;32:2594\u2013603.","journal-title":"Eur Radiol"},{"key":"2033_CR17","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","volume":"43","author":"C Rapezzi","year":"2022","unstructured":"Rapezzi C, Aimo A, Barison A, Emdin M, Porcari A, Linhart A, et al. Restrictive cardiomyopathy: definition and diagnosis. Eur Heart J. 2022;43:4679\u201393.","journal-title":"Eur Heart J"},{"key":"2033_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41:255\u2013323.","journal-title":"Eur Heart J"},{"key":"2033_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/ehjci\/jey123","volume":"20","author":"CC Nwabuo","year":"2019","unstructured":"Nwabuo CC, Moreira HT, Vasconcellos HD, Mewton N, Opdahl A, Ogunyankin KO, et al. Left ventricular global function index predicts incident heart failure and cardiovascular disease in young adults: the coronary artery risk development in young adults (CARDIA) study. Eur Heart J Cardiovasc Imaging. 2019;20:533\u201340.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2033_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","volume":"9","author":"SJ Boynton","year":"2016","unstructured":"Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, et al. Provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis. JACC Cardiovasc Imaging. 2016;9:680\u20136.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2033_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","volume":"18","author":"G Habib","year":"2017","unstructured":"Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, et al. Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document In collaboration with the \u201cWorking Group on myocardial and pericardial diseases\u201d of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18:1090\u2013121.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2033_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","volume":"124","author":"HC Kenny","year":"2019","unstructured":"Kenny HC, Abel ED. Heart failure in type 2 diabetes mellitus. Circ Res. 2019;124:121\u201341.","journal-title":"Circ Res"},{"key":"2033_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12933-020-01167-5","volume":"19","author":"M-Z Wu","year":"2020","unstructured":"Wu M-Z, Lee C-H, Chen Y, Yu S-Y, Yu Y-J, Ren Q-W, et al. Association between adipocyte fatty acid-binding protein with left ventricular remodelling and diastolic function in type 2 diabetes: a prospective echocardiography study. Cardiovasc Diabetol. 2020;19:197.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR24","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1007\/s00330-022-08800-9","volume":"32","author":"X Liu","year":"2022","unstructured":"Liu X, Gao Y, Guo Y-K, Xia C-C, Shi R, Jiang L, et al. Cardiac magnetic resonance T1 mapping for evaluating myocardial fibrosis in patients with type 2 diabetes mellitus: correlation with left ventricular longitudinal diastolic dysfunction. Eur Radiol. 2022;32:7647\u201356.","journal-title":"Eur Radiol"},{"key":"2033_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-021-01303-9","volume":"20","author":"CD Cohen","year":"2021","unstructured":"Cohen CD, De Blasio MJ, Lee MKS, Farrugia GE, Prakoso D, Krstevski C, et al. Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition. Cardiovasc Diabetol. 2021;20:116.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18:149\u201366.","journal-title":"Heart Fail Rev"},{"key":"2033_CR27","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.120.315899","volume":"126","author":"LR Peterson","year":"2020","unstructured":"Peterson LR, Gropler RJ. Metabolic and molecular imaging of the diabetic cardiomyopathy. Circ Res. 2020;126:1628\u201345.","journal-title":"Circ Res"},{"key":"2033_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12968-018-0472-9","volume":"20","author":"K Yoneyama","year":"2018","unstructured":"Yoneyama K, Venkatesh BA, Wu CO, Mewton N, Gjesdal O, Kishi S, et al. Diabetes mellitus and insulin resistance associate with left ventricular shape and torsion by cardiovascular magnetic resonance imaging in asymptomatic individuals from the multi-ethnic study of atherosclerosis. J Cardiovasc Magn Reson. 2018;20:53.","journal-title":"J Cardiovasc Magn Reson"},{"key":"2033_CR29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jcmg.2018.06.016","volume":"12","author":"PE Bravo","year":"2019","unstructured":"Bravo PE, Fujikura K, Kijewski MF, Jerosch-Herold M, Jacob S, El-Sady MS, et al. Relative apical sparing of myocardial longitudinal strain is explained by regional differences in total amyloid mass rather than the proportion of\u00a0amyloid deposits. JACC Cardiovasc Imaging. 2019;12:1165\u201373.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2033_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","volume":"43","author":"OC Cohen","year":"2022","unstructured":"Cohen OC, Ismael A, Pawarova B, Manwani R, Ravichandran S, Law S, et al. Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. Eur Heart J. 2022;43:333\u201341.","journal-title":"Eur Heart J"},{"key":"2033_CR31","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/eurjpc\/zwaa007","volume":"28","author":"L Van Ryckeghem","year":"2021","unstructured":"Van Ryckeghem L, Keytsman C, Verboven K, Verbaanderd E, Frederix I, Bakelants E, et al. Exercise capacity is related to attenuated responses in oxygen extraction and left ventricular longitudinal strain in asymptomatic type 2 diabetes patients. Eur J Prev Cardiol. 2021;28:1756\u201366.","journal-title":"Eur J Prev Cardiol"},{"key":"2033_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-022-01540-6","volume":"21","author":"S Ai","year":"2022","unstructured":"Ai S, Wang X, Wang S, Zhao Y, Guo S, Li G, et al. Effects of glycemic traits on left ventricular structure and function: a mendelian randomization study. Cardiovasc Diabetol. 2022;21:109.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12933-021-01404-5","volume":"20","author":"S Todo","year":"2021","unstructured":"Todo S, Tanaka H, Yamauchi Y, Yokota S, Mochizuki Y, Shiraki H, et al. Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20:212.","journal-title":"Cardiovasc Diabetol"},{"key":"2033_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","volume":"54","author":"LJ Rijzewijk","year":"2009","unstructured":"Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HWAM, Lubberink M, Romijn JA, et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol. 2009;54:1524\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"2033_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, et al. Noncontrast magnetic resonance for the\u00a0diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2020;13:69\u201380.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02033-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:16:10Z","timestamp":1700475370000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02033-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2033"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02033-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3315121\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Biomedical Research Ethics Committee of our hospital. Informed consent was waived due to the retrospective nature of the research. The patient\u2011sensitive data were protected with full confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}